Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 12/22/2014 7:38:44 PM - Followers: 1131 - Board type: Free - Posts Today: 90
PostSubject
#185027  Sticky Note ACHN—With the release of today’s monotherapy data (#msg-109273133), DewDiligence 12/22/14 02:21:29 PM
#185019  Sticky Note ESRX’s own PR on ABBV deal for Viekira Pak: DewDiligence 12/22/14 01:04:33 PM
#185018  Sticky Note KITE submits IND for KTE-C19 (CAR-T) in rNHL: DewDiligence 12/22/14 12:56:53 PM
#185002  Sticky Note MGNX > J&J steps up with $700M deal biocqr 12/22/14 10:45:05 AM
#184989  Sticky Note Could ESPX/ABBV "collusion" to freeze JnJ and Gilead DewDiligence 12/22/14 09:40:41 AM
#184936  Sticky Note When ENTA collects another $75M milestone for formal DewDiligence 12/21/14 02:09:24 PM
#185058   the market thinks the overall size of the zipjet 12/22/14 07:38:44 PM
#185057   It would be a rationalization if I gave justrpaul 12/22/14 07:38:30 PM
#185056   >> Another scenario is Miller did a deal jq1234 12/22/14 07:23:41 PM
#185054   Any connection of the ESRX news to FMI DewDiligence 12/22/14 07:07:00 PM
#185053   …it is not necessarily the case that…the market DewDiligence 12/22/14 07:05:34 PM
#185052   Dew Do you think that today's news regarding stuartscott8900 12/22/14 07:05:28 PM
#185051   Given your appropriate efficient -market hypothesis quote, it justrpaul 12/22/14 07:02:56 PM
#185050   The lack of increase in the ABBV price DewDiligence 12/22/14 06:55:38 PM
#185049   Thus, on the loss of $3.2B in revenue, Rocky3 12/22/14 06:49:13 PM
#185048   JP Morgan ghmm 12/22/14 06:43:41 PM
#185047   ALDR seeks to sell $132.2M* of stock on DewDiligence 12/22/14 06:37:20 PM
#185046   >> The express scripts formulary action applies to jq1234 12/22/14 06:36:52 PM
#185045   [As a reminder, AbbVie announced a list price jbog 12/22/14 06:21:06 PM
#185044   OHRP—I missed this PR from mid-2014: DewDiligence 12/22/14 06:01:58 PM
#185043   Nice math work. zipjet 12/22/14 05:58:37 PM
#185042   That shouldn’t be an epiphany for regular readers DewDiligence 12/22/14 04:59:45 PM
#185041   More to come? Much of high flying biotech north40000 12/22/14 04:56:08 PM
#185040   ABT acquires private AF-device company for $250M in cash: DewDiligence 12/22/14 04:50:15 PM
#185039   Mistake - forgot to subtract non-GT1s, only 77,550. justrpaul 12/22/14 04:43:07 PM
#185038   So this action applies to only 117,500 pollyvonwog 12/22/14 04:08:36 PM
#185037   ENTA +10%—all-time intraday ($51.47) and closing ($51.31) highs. DewDiligence 12/22/14 04:02:41 PM
#185036   Story in Milwaukee newspaper questions validity of HbA1c DewDiligence 12/22/14 03:52:10 PM
#185035   BMY issues most laconic PR I’ve seen in DewDiligence 12/22/14 03:45:04 PM
#185034   CTIX -4% despite nominally positive results in phase-2b trial: DewDiligence 12/22/14 03:34:53 PM
#185033   Survey results: Viekira Pak Pricing (#msg-109260840) DewDiligence 12/22/14 03:14:12 PM
#185032   FDA grants Accelerated Approval for BMY’s Opdivo in DewDiligence 12/22/14 02:54:24 PM
#185031   In a research report published this morning, Needham ariadndndough 12/22/14 02:50:24 PM
#185030   NVS now owns 50 million shares of BLRX ronpopeil 12/22/14 02:49:29 PM
#185029   Citation for prior post: justrpaul 12/22/14 02:35:10 PM
#185028   Some calculations from the 2013 Milliman HCV report justrpaul 12/22/14 02:34:15 PM
#185027   ACHN—With the release of today’s monotherapy data (#msg-109273133), DewDiligence 12/22/14 02:21:29 PM
#185026   Yes, Wells’ 4Q14 numbers for GILD won’t be DewDiligence 12/22/14 02:18:03 PM
#185025   "If the Wells write-up was issued before this north40000 12/22/14 02:09:37 PM
#185024   If the Wells write-up was issued before this DewDiligence 12/22/14 01:59:43 PM
#185023   From Wells: Rocky3 12/22/14 01:51:49 PM
#185022   Makes sense. Thanks. willyw 12/22/14 01:18:30 PM
#185021   GT4 prevalence in the US is de minimis; DewDiligence 12/22/14 01:13:51 PM
#185020   RE: what you highlighted in red willyw 12/22/14 01:10:39 PM
#185019   ESRX’s own PR on ABBV deal for Viekira Pak: DewDiligence 12/22/14 01:04:33 PM
#185018   KITE submits IND for KTE-C19 (CAR-T) in rNHL: DewDiligence 12/22/14 12:56:53 PM
#185017   Quiz hint (#msg-109252362): The typos in the AASLD DewDiligence 12/22/14 12:27:57 PM
#185016   That’s what I would try to be doing DewDiligence 12/22/14 12:26:28 PM
#185015   Novartis Reports 12.8% Passive Stake in BioLineRx as ronpopeil 12/22/14 12:20:30 PM
#185014   On the contrary, would you think Gild will jbog 12/22/14 12:19:20 PM
#185013   NAVB Anyone explain the recent strength. Don't see any PJO 12/22/14 12:02:33 PM
#185012   I awaken to a new world every day. willyw 12/22/14 11:40:21 AM
#185011   Another blow hard from the street.com gang is linhdtu 12/22/14 11:37:31 AM
#185010   Knee jerk reaction. Mr Mkt is quite bipolar linhdtu 12/22/14 11:30:48 AM
#185009   Medivir is still nominally involved in HCV, but DewDiligence 12/22/14 11:25:58 AM
#185008   ABBV now down too---a full fledged pricing war north40000 12/22/14 11:22:46 AM
PostSubject